Compare Albemarle Corp. (ALB) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Albemarle Corp. vs 10X Genomics Inc — how do they compare? Albemarle Corp. trades at $132 (market cap $15.27B), while 10X Genomics Inc trades at $58.6 (market cap $7.61B). The key difference: Albemarle Corp. is far larger — about 2× 10X Genomics Inc's market cap, and Albemarle Corp. pays a 1.27% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| ALB | TXG | |
|---|---|---|
Market Cap | $15.27B | $7.61B |
Sector | Basic Materials | Health |
52-Week High | $215.62 | $58.57 |
52-Week Low | $72.58 | $11.34 |
Enterprise Value | $17.75B | $7.14B |
Dividend Yield | 1.27% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Albemarle Corp.
Albemarle is the world's largest lithium producer. Our outlook for robust lithium demand is predicated upon increased demand for electric vehicle batteries. Albemarle produces lithium from its salt brine deposits in Chile and the U.S. and its hard rock joint venture mines in Australia. Albemarle is also a global leader in the production of bromine, used in flame retardants. The company is also a major producer of oil refining catalysts.
Read more on ALB →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
